Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W
DAK-Gesundheit tender for Healthcare & Medical, value not disclosed, published in September 2024.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tapendadol (ausschl. Wirkstärke 25 mg in der Normgröße N3), ATC N02AX06 f. d. Z. 01.11.24 - 31.10.26
Other tenders · DAK-Gesundheit
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-281792-2026-3Not disclosed17 Sep 2024 Healthcare
- ocds-ted-281792-2026-2Not disclosed17 Sep 2024 Healthcare
- ocds-ted-281792-2026-1Not disclosed17 Sep 2024 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime